Medical literature search: PD-1/PD-L1 NSCLC immunotherapy

Task Goal

Validate paper-search-pro on a cross-disciplinary literature discovery scenario.

Run literature discovery with the Crossref source and retain raw JSON evidence.

Plasma Cell-free RNA PD-L1 Compared to Tissue PD-L1 Protein Expression and Outcomes with First-line Immunotherapy in Metastatic Non-small Cell Lung Cancer (2023)
- Authors: Paul R. Walker, Sriraksha Jayananda, Melisa Pasli, Mahvish Muzaffar
- Source: Crossref; ID: 10.20944/preprints202306.1358.v1
Clinical Efficacy of Immunotherapy with Pd-1/Pd-L1 Inhibitors for the Treatment of Advanced Non-Small Cell Lung Cancer (2020)
- Authors: No authors listed
- Source: 2020 International Clinical & Experimental Pharmacology and Oncology Forum (ICEPOF 2020); ID: 10.48062/978-1-7773850-1-9.011
Targeting PD-L1 for Non-Small-Cell Lung Cancer (2016)
- Authors: Emily Feld, Leora Horn
- Source: Immunotherapy; ID: 10.2217/imt-2016-0012
PD-L1 biomarker testing for non-small cell lung cancer: truth or fiction? (2016)
- Authors: Claud Grigg, Naiyer A. Rizvi
- Source: Journal for ImmunoTherapy of Cancer; ID: 10.1186/s40425-016-0153-x
Correlative Factors of PD-1/PD-L1 Inhibitors-based Immunotherapy Responses in Non-small Cell Lung Cancer (2024)
- Authors: Caiwei Wang
- Source: Transactions on Materials, Biotechnology and Life Sciences; ID: 10.62051/mgznvq03

Internal raw JSON: outputs/tasks/literature-discovery/ld-medical-pd1/raw/crossref_results.json
Internal structured output: outputs/tasks/literature-discovery/ld-medical-pd1/output.md

PASS。 This task is part of the corrected public package covering Medicine, Physics, Chemistry, Biology, and Computer Science.